⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18426934 | 0.65 | — | — | |
| SCHEMBL1972780 | 0.58 | — | — | |
| SCHEMBL3212122 | 0.56 | — | — | |
| SCHEMBL3065640 | 0.56 | — | — | |
| SCHEMBL3058595 | 0.56 | — | — | |
| SCHEMBL276996 | 0.52 | — | — | |
| SCHEMBL6685686 | 0.52 | — | — | |
| SCHEMBL7175347 | 0.52 | — | — | |
| SCHEMBL3084266 | 0.52 | — | — | |
| SCHEMBL8052375 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7427675-B2 | Compounds and methods for the characterization of oligonucleotides | ISIS PHARMACEUTICALS, INC. (US) | 2008-09-23 | — | — | US | disclosed |
| WO-2006023880-A2 | COMPOUNDS AND METHODS FOR THE CHARACTERIZATION OF OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20060040308-A1 | Compounds and methods for the characterization of oligonucleotides | ISIS PHARMACEUTICALS, INC. (US) | 2006-02-23 | — | — | US | disclosed |